We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+5.3%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$342B
AUM Growth
+$4.99B
(+1.5%)
Cap. Flow
-$5.86B
Cap. Flow
% of AUM
-1.71%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
3,487
New
211
Increased
1,344
Reduced
1,316
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.03B |
| 2 |
Valero Energy
VLO
|
+$273M |
| 3 |
Progressive
PGR
|
+$259M |
| 4 |
Advanced Micro Devices
AMD
|
+$256M |
| 5 |
O'Reilly Automotive
ORLY
|
+$232M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$466M |
| 2 |
NVIDIA
NVDA
|
+$435M |
| 3 |
Intel
INTC
|
+$426M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$389M |
| 5 |
Merck
MRK
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Financials | 11.71% |
| 3 | Healthcare | 11.09% |
| 4 | Consumer Discretionary | 10.64% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MORF
1976
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $4.49M | ﹤0.01% |
131,695
+4,993
| +4% | +$148K |
|
1977
Astrana Health
ASTH
$1.77B
| $4.48M | ﹤0.01% |
110,562
+2,767
| +3% | +$110K |
|
1978
Green Plains
GPRE
$1.03B
| $4.48M | ﹤0.01% |
282,514
+6,615
| +2% | +$127K |
|
|
ARI
1979
Apollo Commercial Real Estate
ARI
$885M
| $4.47M | ﹤0.01% |
453,448
-48,642
| -10% | -$502K |
|
1980
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $4.46M | ﹤0.01% |
50,370
-45,130
| -47% | -$4M |
|
1981
Legend Biotech
LEGN
$4.01B
| $4.45M | ﹤0.01% |
100,586
-1,500
| -1% | -$69.2K |
|
1982
Gogo Inc
GOGO
$493M
| $4.45M | ﹤0.01% |
462,332
+3,680
| +0.8% | +$34.9K |
|
1983
Merchants Bancorp
MBIN
$2.49B
| $4.44M | ﹤0.01% |
109,491
+65,259
| +148% | +$2.68M |
|
1984
VSE Corp
VSEC
$6.12B
| $4.43M | ﹤0.01% |
50,148
+2,366
| +5% | +$190K |
|
1985
Altimmune
ALT
$599M
| $4.42M | ﹤0.01% |
665,058
-247,942
| -27% | -$1.83M |
|
|
MTTR
1986
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $4.42M | ﹤0.01% |
988,305
+173,155
| +21% | +$656K |
|
|
HTBK
1987
DELISTED
Heritage Commerce
HTBK
| $4.42M | ﹤0.01% |
507,656
+3,736
| +0.7% | +$30.4K |
|
1988
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $4.41M | ﹤0.01% |
8,088
-469
| -5% | -$245K |
|
1989
Nuvation Bio
NUVB
$2.32B
| $4.4M | ﹤0.01% |
1,506,170
+630,808
| +72% | +$1.92M |
|
1990
iShares MBS ETF
MBB
$39.1B
| $4.39M | ﹤0.01% |
47,860
| – | – |
|
1991
Amalgamated Financial
AMAL
$1.49B
| $4.39M | ﹤0.01% |
160,236
+8,969
| +6% | +$219K |
|
1992
Papa John's
PZZA
$806M
| $4.38M | ﹤0.01% |
93,309
-201,490
| -68% | -$11M |
|
1993
Edgewise Therapeutics
EWTX
$4.73B
| $4.38M | ﹤0.01% |
243,098
-94,906
| -28% | -$1.66M |
|
|
JBGS
1994
JBG SMITH
JBGS
$708M
| $4.37M | ﹤0.01% |
287,151
-553,000
| -66% | -$8.19M |
|
1995
SFL Corp
SFL
$1.61B
| $4.36M | ﹤0.01% |
314,297
+8,584
| +3% | +$116K |
|
1996
Horace Mann Educators
HMN
$2.11B
| $4.35M | ﹤0.01% |
133,324
+14,860
| +13% | +$520K |
|
1997
Beam Therapeutics
BEAM
$2.84B
| $4.33M | ﹤0.01% |
184,596
+10,405
| +6% | +$256K |
|
1998
Rocket Companies
RKT
$38.9B
| $4.32M | ﹤0.01% |
315,686
-164,399
| -34% | -$2.22M |
|
|
LBPH
1999
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $4.32M | ﹤0.01% |
159,989
+20,094
| +14% | +$396K |
|
2000
Horizon Bancorp
HBNC
$1.04B
| $4.3M | ﹤0.01% |
347,398
+2,657
| +0.8% | +$31.9K |
|
Similar funds
VFT
Nuveen's Q2 2024 Portfolio in Review
As of Q2 2024, Nuveen held 3,487 positions worth $342B, up 1.5% from $337B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Nuveen's Q2 2024 filing shows 211 new, 1,344 increased, 1,316 reduced and 159 closed positions. Its largest new stake was GE Vernova: 595,802 shares worth $102M. The largest sale was Meta Platforms (Facebook), an estimated $466M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q2 2024 buy was GE Vernova: 595,802 shares worth $102M.
- Nuveen added most to Apple in Q2 2024, an estimated $1.03B increase.
- Nuveen's biggest Q2 2024 reduction was Meta Platforms (Facebook), cutting an estimated $466M.
- Nuveen fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $389M.
- Nuveen's ten largest holdings make up 32% of its $342B portfolio in Q2 2024.
- Nuveen opened 211 new positions and closed 159 in Q2 2024.
- Nuveen's portfolio value rose 1.5% quarter-over-quarter to $342B.
Based on Nuveen's 13F filing for Q2 2024, filed 9 Aug 2024.